Salil Narang
About Salil Narang
Data last updated:
Salil Narang is a Director at Neuclia Pathlabs Private Limited (since 2023) and Director at Unipath Diagnostics Private Limited (since 2022). The companies operate in Healthcare. The largest current company by reported revenue is Neuclia Pathlabs Private Limited at ₹35.5 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Neuclia Pathlabs Private Limited U85100HR2023PTC109278 | Director | 18 Jan 2023 | 2023 | ₹35.5 Lakh (FY 2025) | Active |
| Unipath Diagnostics Private Limited U85300DL2022PTC397295 | Director | 26 Apr 2022 | 2022 | Active |
Board colleagues of Salil Narang
| Name | DIN | Company | Designation |
|---|---|---|---|
| Neha Chopra Narang | 09861548 | Neuclia Pathlabs Private Limited | Director |
| Raj Kumar Narang | 09585718 | Unipath Diagnostics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Salil Narang
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Salil Narang
Salil Narang currently holds 2 directorships: Neuclia Pathlabs Private Limited (Director, since 18 Jan 2023, revenue ₹35.5 Lakh (FY 2025)); Unipath Diagnostics Private Limited (Director, since 26 Apr 2022).
Salil Narang was first appointed on 26 Apr 2022 as Director at Unipath Diagnostics Private Limited. The most recent appointment on record is 18 Jan 2023 at Neuclia Pathlabs Private Limited.
The current boards of Salil Narang's companies include Neha Chopra Narang (Neuclia Pathlabs Private Limited), Raj Kumar Narang (Unipath Diagnostics Private Limited).